Danazol-beta-cyclodextrin binary system: a potential application in emergency contraception by the oral route
- PMID: 17622113
- PMCID: PMC2750374
- DOI: 10.1208/pt0802035
Danazol-beta-cyclodextrin binary system: a potential application in emergency contraception by the oral route
Abstract
This study explored the potential of beta-cyclodextrin to improve the aqueous solubility and dissolution of danazol, investigated a simple and less expensive method for preparation of a danazol-beta-cyclodextrin binary system, and explored the potential application of a danazol-beta-cyclodextrin binary system as a single-dose emergency contraceptive. Phase solubility analysis indicated formation of a first-order soluble complex with stability constant 972.03 M(-1), while Job's plot affirmed 1:1 stoichiometry. The hyperchromic shift in the UV-Vis spectrum of danazol in the presence of beta-cyclodextrin indicated solubilization capability of beta-cyclodextrin for danazol. The extrinsic Cotton effect with a negative peak at 280.7 nm confirmed the inclusion of danazol in the asymmetric locus of beta-cyclodextrin. (1)H-nuclear magnetic resonance analysis suggested that the protons of the steroidal skeleton of danazol display favorable interactions with the beta-cyclodextrin cavity. The danazol-beta-cyclodextrin binary system was prepared by kneading, solution, freeze-drying, and milling methods. The extent of the enhancement of dissolution rate was found to be dependent on the preparation method. Dissolution studies showed a similar relative dissolution rate (2.85) of the danazol-beta-cyclodextrin binary system prepared by the freeze-drying and milling (in the presence of 13% moisture) methods. In a mouse model, the danazol-beta-cyclodextrin binary system at 51.2 mg/kg (equivalent to a 400-mg human dose) showed 100% inhibition of implantation when given postcoitally. Moreover, the danazol-beta-cyclodextrin binary system is safe up to 2000 mg/kg in the mouse (15.52 g/70 kg human) as a single oral dose. Thus, the danazol-beta-cyclodextrin binary system could serve as a new therapeutic application: an oral emergency contraceptive at a physiologically acceptable single dose.
References
-
- Kistner RW, editor. Gynecology: Principles and Practice. Chicago, IL: Year Book Medical Publishers; 1971.
-
- Dmowski WP. Endocrine properties and clinical applications of danazol. Fertil Steril. 1979;31:237–251. - PubMed
-
- Dmowski WP, Cohen MR. Antigonadotropin (danazol) in the treatment of endometriosis. Evaluation of post-treatment fertility and three-year follow-up data. Am J Obstet Gynecol. 1978;130:41–48. - PubMed
-
- Lauersen NH, Wilson KH. The effect of danazol in the treatment of chronic cystis mastitis. Obstet Gynecol. 1976;48:93–98. - PubMed
-
- Lee PA, Thompson RG, Migeon CJ, Blizzard RM. The effect of danazol in sexual precocity. Johns Hopkins Med J. 1975;137:265–269. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources